This morning, UBS decreased its price target on shares of Quest Diagnostics (NYSE:DGX) to $56 as unusually cold weather will impact the company's first quarter results. In the report, UBS maintained its neutral rating. Shares of Quest Diagnostics were lower by 0.7% on Friday.
And Jefferies reduced its price target on shares of Invesco (NYSE:IVZ) to $40 as changes to the portfolio management team could create outflows. In the report, Jefferies maintained its buy rating. Shares of Invesco were lower by 1.5% on the news.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.